The body uses a number of inflammatory and immune responses to promote clinical and experimental graft rejection. Various clinical strategies have been designed to treat transplantation patients who develop acute and hyperacute rejection.
Keywords: alloantibodies; allograft; antigen-presenting cells; autograft; chronic rejection; cytokines; endothelial cells; hyperacute rejection; immunosuppression; inflammation; major histocompatibility complex; T cells; transplantation; xenograft







